サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1661075

肺マーカー市場レポート：がんタイプ、マーカータイプ、エンドユーザー、地域別、2025年～2033年

Lung Marker Market Report by Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Marker Type (EGFR, EML4-ALK, KRAS, BRAF, and Others), End User (Hospitals, Diagnostic Labs, and Others), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 150 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
肺マーカー市場レポート：がんタイプ、マーカータイプ、エンドユーザー、地域別、2025年～2033年
出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肺マーカーの世界市場規模は2024年に4億8,220万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに11億460万米ドルに達し、2025年から2033年にかけて9.6%の成長率（CAGR）を示すと予測しています。

一般に、EGFR、EML4-ALK、KRAS、BRAFを含む4種類の主要な肺マーカーは、肺の介入処置や肺の手術、診断の際に使用されます。さらに、マーカーは腫瘍の検出、診断、予測、モニタリングに使用され、それに基づいて患者に治療が処方されます。肺マーカーは、いくつかの画像検査や生検とともに、がんを特定するための追加ツールとしてのみ使用されます。このため、肺マーカーは、病院、外来外科クリニック、専門クリニックなど、いくつかのヘルスケア施設の胸腔鏡手術で広く使用されています。

肺マーカーの需要が高まっている背景には、大気汚染レベルの上昇による胸水、胸膜中皮腫、胸膜プラークなどの呼吸器疾患の有病率の上昇があります。これに加えて、受動喫煙への高い曝露と肺がんの家族歴が、肺がんに罹患する患者数をさらに増加させ、肺マーカーの需要を増大させる。さらに、老年人口の急増と、喫煙率の高さにつながる多忙な消費者のライフスタイルが、いくつかの呼吸器疾患のリスクをさらに加速させています。これとは別に、肺がんなどの生命を脅かす疾患の早期診断と前治療のために、さまざまな政府によるヘルスケア支出が増加していることも、世界レベルでの肺マーカーの利用増加を後押ししています。さらに、肺がんの診断と治療の分野におけるいくつかの研究開発活動への投資が増加していることも、肺マーカーの需要をさらに刺激しています。これに加えて、病院、手術センター、診療所での肺マーカーの使用量の増加や、治療目的でのさまざまな用途も、製品需要を刺激しています。

本レポートで扱う主な質問

  • 世界の肺マーカー市場はこれまでどのように推移してきたか？
  • COVID-19は世界の肺マーカー市場にどのような影響を与えているか？
  • 主要地域市場とは？
  • がんタイプ別の市場内訳は？
  • マーカータイプ別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の肺マーカー市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の肺マーカー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：がんタイプ別

  • 非小細胞肺がん（NSCLC）
    • 市場動向
    • 市場予測
  • 小細胞肺がん（SCLC）
    • 市場動向
    • 市場予測

第7章 市場内訳：マーカータイプ別

  • EGFR
    • 市場動向
    • 市場予測
  • EML4-ALK
    • 市場動向
    • 市場予測
  • KRAS
    • 市場動向
    • 市場予測
  • BRAF
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診断ラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
    • ペルー
    • その他
  • 中東・アフリカ
    • トルコ
    • イラン
    • その他

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格指標

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc.
    • Fujirebio Europe N.V.
    • Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • BioSpace, Inc.
図表

List of Figures

  • Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
  • Figure 2: Global: Lung Marker Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2024
  • Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2024
  • Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Turkey: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Iran: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Argentina: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Colombia: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Chile: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Peru: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Others: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Lung Marker Industry: SWOT Analysis
  • Figure 91: Global: Lung Marker Industry: Value Chain Analysis
  • Figure 92: Global: Lung Marker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Lung Marker Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million USD), 2025-2033
  • Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million USD), 2025-2033
  • Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Lung Marker Market: Competitive Structure
  • Table 7: Global: Lung Marker Market: Key Players
目次
Product Code: SR112025A2063

The global lung marker market size reached USD 482.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,104.6 Million by 2033, exhibiting a growth rate (CAGR) of 9.6% during 2025-2033.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

Breakup by Cancer Type:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Labs
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Others
  • Middle East and Africa
  • Turkey
  • Iran
  • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Lung Marker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Non-Small Cell Lung Cancer (NSCLC)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Cell Lung Cancer (SCLC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Marker Type

  • 7.1 EGFR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 EML4-ALK
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 KRAS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 BRAF
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Iran
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Others
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Thermo Fisher Scientific Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agilent Technologies, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fujirebio Europe N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hologic, Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Siemens Healthineers
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 BioSpace, Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis